| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2980684 | The Journal of Thoracic and Cardiovascular Surgery | 2014 | 15 Pages |
Abstract
This study demonstrates that treatment with PMSCs is protective against the development of bronchiolitis obliterans in an heterotopic tracheal transplant model. These results indicate that PMSCs could provide a novel therapeutic option to reduce chronic rejection after lung transplant.
Keywords
TNFpMSCPBShttGM-CSFMSCIL-1RADAPIhpfH&EInterleukin 1 receptor antagonistinterleukinbronchiolitis obliteransMesenchymal stem cellsgranulocyte colony-stimulating factorG-CSFtumor necrosis factorgranulocyte macrophage colony-stimulating factorPhosphate-buffered salinehigh-power fieldHematoxylin and Eosin
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yunge MD, PhD, Jacob R. MD, David A. BS, Irving L. MD, Michael P. MD, FACS, Christine L. MD, MBA,